SCHEMBL9019807

SCHEMBL9019807

CC(=O)Nc1ncc2c(ncn2COC(COC(C)C)COC(C)C)n1

nearest known ligand 0.32

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE3A Q14432 1/20 0.32
CYP3A4 P08684 2/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
CCR4 P51679 1/20 0.31
SMN1; SMN2 Q16637 2/20 0.30
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
NFKB1 P19838 1/20 0.30
BLM P54132 1/20 0.30
VCP P55072 1/20 0.30
KMT2A Q03164 1/20 0.30
HIF1A Q16665 1/20 0.30
HTT P42858 1/20 0.30
MAPT P10636 1/20 0.30
TKT P29401 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9019764 0.95 PDE3A (0.38) PDE3ACYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL9019826 0.89 ALDH1A1 (0.37) PDE3ACYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL9019800 0.89 BCHE (0.38) CYP3A4CYP2D6CYP2C9CYP2C19MEN1
SCHEMBL9845278 0.88 SYK (0.31) CYP3A4CYP2D6CYP2C9CYP2C19CCR4
SCHEMBL9019796 0.88 CYP3A4 (0.41) PDE3ACYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL9845246 0.85 BCHE (0.36) CYP3A4CYP2D6CYP2C9CYP2C19MEN1
SCHEMBL9845279 0.85 MEN1 (0.39) CCR4SMN1; SMN2MEN1KMT2AHTT
SCHEMBL9019788 0.85 ACACB (0.37) MEN1ALDH1A1LMNAKMT2AHTT
SCHEMBL9019742 0.84 ACHE (0.33) PDE3ACYP3A4SMN1; SMN2MEN1ALDH1A1
SCHEMBL9575559 0.83 ALDH1A1 (0.41) PDE3ACYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0452680-B1 Substituted purines, process for their preparation and their use as antiviral agents HOECHST AG (DE) 1996-11-06 EP disclosed
EP-0452680-A1 Substituted purines, process for their preparation and their use as antiviral agents HOECHST AKTIENGESELLSCHAFT (DE) 1991-10-23 EP disclosed